Dataset from A Randomized, Open-label Study of Ponatinib Versus Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase Following Resistance to Imatinib
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009656
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to compare the efficacy and safety of 2 starting doses of
ponatinib compared to nilotinib in participants with imatinib-resistant chronic myeloid
leukemia (CML) in chronic phase (CP).
创建时间：
2024-11-26
